SCHEMBL4932704

SCHEMBL4932704

O=C(NC(=O)c1ccccc1)NC(CCc1c[nH]c2ccccc12)c1ccc(C(=O)NO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
SIRT1 Q96EB6 3/20 0.48
CDK4 P11802 3/20 0.48
CCND1 P24385 3/20 0.48
MAPT P10636 1/20 0.48
HDAC3 O15379 7/20 0.48
HDAC1 Q13547 7/20 0.48
HDAC2 Q92769 7/20 0.48
HDAC6 Q9UBN7 7/20 0.48
HDAC8 Q9BY41 7/20 0.46
HDAC4 P56524 6/20 0.46
HDAC7 Q8WUI4 6/20 0.46
HDAC10 Q969S8 6/20 0.46
HDAC11 Q96DB2 6/20 0.46
HDAC9 Q9UKV0 6/20 0.46
HDAC5 Q9UQL6 6/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4932423 0.89 GPR84 (0.49) MEN1KMT2ANPC1RAB9ASIRT1
SCHEMBL4922579 0.89 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC6HDAC8
SCHEMBL4931914 0.85 HDAC3 (0.50) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL23100769 0.78 KMT2A (0.56) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL23100771 0.78 KMT2A (0.56) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL4934375 0.77 HDAC8 (0.58) MEN1KMT2ANPC1RAB9AHDAC3
SCHEMBL4931261 0.77 HDAC1 (0.49) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL4925108 0.75 RAB9A (0.48) MEN1KMT2ANPC1RAB9AHDAC3
SCHEMBL4930143 0.73 HDAC1 (0.50) HDAC3HDAC1HDAC2HDAC6HDAC8
SCHEMBL4932696 0.72 HDAC1 (0.69) MEN1KMT2ANPC1RAB9ACDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US claimed
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates S*BIO PTE LTD. (SG) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070954-A1 Acylurea Connected And Sulfonylurea Connected Hydroxamates HDAC1, HDAC3, HDAC4 MEN1 2737/4885KMT2A 105/4885NPC1 2664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.